CRMD has been in the news 900% more than usual
Jun 27, 2025, 2:32 PM
-9.18%
What does CRMD do
CorMedix is a pharmaceutical company based in New Jersey, focused on developing therapeutic products, notably DefenCath, an antimicrobial solution for preventing catheter-related bloodstream infections in kidney failure patients. The company went public in 2010 and has also sponsored research on taurolidine for rare pediatric tumors.
CRMD has been in the news recently: CORMEDIX is not directly mentioned in the provided information, but the stock market context indicates that while some companies like Gainers are experiencing profit increases, others like Nike are facing challenges with declining sales. Overall, U.S. stock futures are showing a positive trend, with Dow futures rising over 100 points.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.